Preservation of fertility in teenagers and young adults treated for haematological malignancies

Ephia Yasmin, Rod T Mitchell, Sheila Lane

Research output: Contribution to journalArticlepeer-review


As survival rates in teenagers and young adults diagnosed with haematological malignancies now exceed 70%, it is important that long-term quality of life, including measures to protect future fertility, are considered and discussed with patients and their families. Although discussion on the effect of planned cancer treatment on fertility is standard of care, knowledge of potential fertility treatment options and when they should be offered in haematological malignancies is not always so clear. In each case, the advice on the appropriate preservation of fertility depends upon a complex interplay of factors, weighing out the risk of future infertility against the risk of fertility preservation treatment, and recommendations must be made on a case-by-case basis. The aim of this Review is to evaluate the gonadotoxicity of treatments of prevalent haematological malignancies in teenagers and young adults, and provide an evidence-based framework to help with fertility discussion and management at the time of diagnosis, relapse or resistant disease, and in long-term follow-up settings.
Original languageEnglish
Pages (from-to) e149-e160
Number of pages12
JournalThe Lancet Haematology
Issue number2
Early online date26 Jan 2021
Publication statusPublished - 1 Feb 2021


Dive into the research topics of 'Preservation of fertility in teenagers and young adults treated for haematological malignancies'. Together they form a unique fingerprint.

Cite this